TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Roche Diagnostics Scandinavia AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
564,368
|
545,824
|
622,455 |
| Financial expenses |
66
|
12
|
17 |
| Earnings before taxes |
16,998
|
18,100
|
22,116 |
| EBITDA |
41,770
|
37,382
|
45,651 |
| Total assets |
256,041
|
240,048
|
251,196 |
| Current assets |
186,056
|
194,929
|
203,004 |
| Current liabilities |
119,669
|
122,062
|
145,426 |
| Equity capital |
132,047
|
115,804
|
105,310 |
| - share capital |
9,117
|
8,513
|
8,777 |
| Employees (average) |
97
|
97
|
105 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
51.6%
|
48.2%
|
41.9% |
| Turnover per employee |
5,818
|
5,627
|
5,928 |
| Profit as a percentage of turnover |
3.0%
|
3.3%
|
3.6% |
| Return on assets (ROA) |
6.7%
|
7.5%
|
8.8% |
| Current ratio |
155.5%
|
159.7%
|
139.6% |
| Return on equity (ROE) |
12.9%
|
15.6%
|
21.0% |
| Change turnover |
-20,186
|
-57,924
|
29,635 |
| Change turnover % |
-3%
|
-10%
|
5% |
| Chg. No. of employees |
0
|
-8
|
4 |
| Chg. No. of employees % |
0%
|
-8%
|
4% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.